---
layout: post
title: "和邦生物业绩快报：2021年净利同比增长7284%"
date: 2022-03-03 17:42:11 +0800
categories: shanghaizhengquanbao·zhongguozhengquanwang
tags: 上海证券报·中国证券网新闻
---
<center><p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.603077" data-code="603077|1|1" data-code2="603077|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.603077&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 603077_0" data-code="K 603077|1|1" data-code2="K 603077|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p></center><p><span id="stock_1.603077"><a href="http://quote.eastmoney.com/unify/r/1.603077" class="keytip" data-code="1,603077">和邦生物</a></span><span id="quote_1.603077"></span>发布<span id="Info.3321"><a href="http://data.eastmoney.com/bbsj/" class="infokey">业绩</a></span>快报，2021年公司实现<span id="Info.3323"><a href="http://data.eastmoney.com/bbsj/" class="infokey">营业收入</a></span>9,867,109,124.21元，同比增加87.56%；实现归属于上市公司<span id="Info.3286"><a href="http://data.eastmoney.com/gdfx/" class="infokey">股东</a></span>的<span id="Info.3324"><a href="http://data.eastmoney.com/bbsj/" class="infokey">净利润</a></span>3,023,306,248.16元，同比增加7,284.28%。基本每股收益0.3584元。报告期公司主要产品为双甘膦、草甘膦、纯碱、氯化铵、玻璃，受益于环保要求提升以及落后产能进一步出清、产能扩张受到限制，叠加下游需求增长，从而带动销售价格上涨，使公司能获得合理的运营利润。</p><p class="em_media">（文章来源：上海<span id="bk_90.BK0473"><a href="http://quote.eastmoney.com/unify/r/90.BK0473" class="keytip" data-code="90,BK0473">证券</a></span><span id="bkquote_90.BK0473"></span>报·中国<span web="1" href="http://quote.eastmoney.com/unify/r/90.BK0473" class="em_stock_key_common" data-code="90,BK0473">证券</span>网）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202203032295977984>

[返回上海证券报·中国证券网新闻](//finews.withounder.com/category/shanghaizhengquanbao·zhongguozhengquanwang.html)｜[返回首页](//finews.withounder.com/)